Skip to Content
Merck
  • Nitric oxide and reactive species are modulated in the polyphenol-induced ductus arteriosus constriction in pregnant sheep.

Nitric oxide and reactive species are modulated in the polyphenol-induced ductus arteriosus constriction in pregnant sheep.

Prenatal diagnosis (2014-07-22)
Guilherme B Bubols, Paulo Zielinsky, Antônio L Piccoli, Luiz H Nicoloso, Izabele Vian, Angela M Moro, Mariele F Charão, Natália Brucker, Rachel P Bulcão, Sabrina N Nascimento, Marília Baierle, Marcelo M Alievi, Rafael N Moresco, Melissa Markoski, Solange C Garcia
ABSTRACT

Because we have previously demonstrated the relation between polyphenol-rich foods (PRF) consumption and ductus arteriosus constriction, in this work, pregnant sheep were submitted to oral PRF intake for 14 days to understand how this process occurs. Fetal Doppler echocardiography, oxidative and inflammatory biomarkers and total polyphenol excretion were evaluated. The high polyphenol intake induced ductus arteriosus constriction by 71.6% increase in systolic (P = 0.001) and 57.8% in diastolic velocities (P = 0.002), and 18.9% decrease in pulsatility index (P = 0.033), along with 1.7-fold increase in total polyphenol excretion, 2.3-fold decrease in inflammatory mediator nitric oxide and following redox status changes (mean ± standard deviation): higher protein carbonyls (1.09 ± 0.09 and 1.49 ± 0.31), catalase (0.69 ± 0.39 and 1.44 ± 0.33) and glutathione peroxidase (37.23 ± 11.19 and 62.96 ± 15.03) in addition to lower lipid damage (17.22 ± 2.05 and 12.53 ± 2.11) and nonprotein thiols (0.11 ± 0.04 and 0.04 ± 0.01) found before and after treatment, respectively. Ductal parameters correlated to NOx , catalase, glutathione peroxidase and protein carbonyl. Our results highlight the need to reduce maternal PRF intake in late pregnancy to prevent fetal duct constriction through NO-mediated vasoconstrictive action of polyphenols.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,4-Dinitrophenylhydrazine, reagent grade, 97%
Dinoprostone, European Pharmacopoeia (EP) Reference Standard
USP
Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfanilamide, VETRANAL®, analytical standard
USP
Sulfanilamide, United States Pharmacopeia (USP) Reference Standard
Sulfanilamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Prostaglandin E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Prostaglandin E2, ≥93% (HPLC), synthetic
Sigma-Aldrich
Sulfanilamide, ≥98%
Sigma-Aldrich
Sulfanilamide, puriss. p.a., ≥98% (calc. to the dried substance)